What risk is increased in pregnant patients with rheumatoid arthritis?

Pregnant patients with rheumatoid arthritis are at an increased risk for preterm birth and intrauterine growth restriction due to several factors associated with the disease and its implications during pregnancy.

Rheumatoid arthritis can lead to increased systemic inflammation, which can affect placental function and fetal growth. Inflammatory mediators can impair the blood flow to the placenta and the fetus, which are critical for providing the necessary nutrients and oxygen for healthy development. This can subsequently contribute to intrauterine growth restriction, where the fetus does not grow to its expected size.

Furthermore, the use of certain medications to manage rheumatoid arthritis during pregnancy may also pose risks to fetal development and can play a role in the timing of delivery, potentially leading to preterm birth. It is important for healthcare providers to carefully monitor pregnant patients with rheumatoid arthritis for these risks to ensure optimal management of their condition and the health of both mother and baby.

The other options presented do not directly correlate with the known complications associated with rheumatoid arthritis in pregnancy, making the increased risk for preterm birth and intrauterine growth restriction the most pertinent outcome associated with this condition.